LATEST

• REGULATORY Minister Signals Chuikyo Review of Innovation Incentives after Roadmap
  June 17, 2026

• REGULATORY Limas, Ezharmia Among Drugs Subject to Label Revisions
  June 17, 2026

• REGULATORY MHLW Issues Guidance on Proper Use of GLP-1 Drugs
  June 17, 2026

• COMMENTARY Adaptation, Diversification Key as Drug Wholesalers Face Profit Squeeze
  June 16, 2026

• BUSINESS Ono CEO’s Pay Climbs to 260 Million Yen
  June 16, 2026

• REGULATORY Japan Panel Seeks Easing of Rules on Radiopharma Research Samples
  June 16, 2026

• REGULATORY LDP Team Reviews Draft Industry Cluster Plans for Radiopharma, Blood Products
  June 16, 2026

• BUSINESS Six Eisai Executives Took Home Over 100 Million Yen in FY2025
  June 16, 2026

• BUSINESS Hisamitsu to Raise Prices on Salonpas, Other OTC Products
  June 16, 2026

• BUSINESS Eisai to Invest £48 Million to Build Cold-Chain Capability in UK
  June 16, 2026

• BUSINESS Susmed Bags 240 Million Yen Milestone for Tinnitus App
  June 16, 2026

• BUSINESS Vanflyta Wins China Nod for Frontline AML
  June 16, 2026

• BUSINESS Otsuka Closes US$700 Million Transcend Buyout
  June 16, 2026

• ORGANIZATION Ease Foreign Price Adjustment Rules for New Drugs to Counter MFN Policy: FPMAJ
  June 15, 2026

• ORGANIZATION Raise Foreign Price Adjustment Cap for Listed Products in German Cases: FPMAJ
  June 15, 2026

• ORGANIZATION FPMAJ Seeks Predictability in Price Maintenance System for Innovative Medicines
  June 15, 2026

• BUSINESS Takeda’s Zasocitinib Beats Sotyktu in PIII Psoriasis Trial
  June 15, 2026

• BUSINESS Rakuten Medical CEO-Elect Reaffirms 2028 US Filing Plan for Akalux
  June 15, 2026

• BUSINESS Heartseed Starts Japan PI/II of Catheter-Delivered iPSC Cardiomyocyte Therapy
  June 15, 2026

• BUSINESS Lilly Breaks Ground on New Building at Kobe Plant
  June 15, 2026

ページ

• « 先頭
• ‹ Prev
• …
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• …
• Next ›
• 最終 »